Skip to main content


  • Poster presentation
  • Open Access

Pulmonary melioidosis in CAMBODIA: a prospective study

  • 1Email author,
  • 1,
  • 1,
  • 2,
  • 3,
  • 1,
  • 4,
  • 1,
  • 5,
  • 6,
  • 7,
  • 1 and
  • 1
BMC Proceedings20115 (Suppl 1) :P73

  • Published:


  • Pneumonia
  • Blood Culture
  • Respiratory Infection
  • Hospital Discharge
  • High Fatality

Melioidosis is a disease caused by the soil-dwelling Gram-negative bacterium Burkholderia pseudomallei. It is endemic in South-East Asia but remains poorly documented in Cambodia where laboratory facilities are scarce. We report here a cohort of culture-confirmed cases of pulmonary melioidosis identified in two provincial hospitals in Cambodia, describing clinical and epidemiological characteristics.

Patients with melioidosis were identified through a laboratory based surveillance of acute lower respiratory infections (<14 days of illness) in two provincial hospitals from April 2007 to January 2010. B. pseudomallei was detected in sputum or blood through 42 cultures and confirmed by API 20 NE gallery. We collected clinical, microbiological and radiological data and visited patients several weeks after hospital discharge to document long-term outcome.

Melioidosis was found in 39 patients. The median age was 46 years including three patients ≤2 years and 56.4% were males. A close contact with soil and water was identified in 30 patients (76.9%). Pneumonia was the main radiological feature (82.3%), but pleurisy was also described in 6 patients. Eleven patients were severe. A positive blood culture was significantly associated with severe cases (90.9% vs. 50.0%; p<0.05) and with higher fatality (87.5% vs. 20%; p<0.01). A total of 24 (61.5%) patients died within 3 days, 23 without receiving any active drug against B. pseudomallei. One year after discharge, 11 patients were still alive and considered as cured.

Melioidosis is an emerging public health issue in Cambodia that requires nationwide access to laboratory facilities and timely appropriate treatment.



Supported by the French Development Agency through the Surveillance and Investigation of Epidemic Situations in Southeast Asia (SISEA) project.

Authors’ Affiliations

Epidemiology and Public Health Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia
Biomedical Laboratory, Institut Pasteur in Cambodia, Phnom Penh, Cambodia
Virology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia
Swiss Red Cross, Takeo, Cambodia
Pediatric Department, Donkeo Provincial Hospital, Takeo, Cambodia
Pediatric Department, Provincial Hospital, Kampong Cham, Cambodia
Pneumology and Intensive Care Unit, Hôpital Tenon, Paris, France


© Rammaert et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.